{"id":505637,"date":"2021-06-22T16:10:23","date_gmt":"2021-06-22T20:10:23","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\/"},"modified":"2021-06-22T16:10:23","modified_gmt":"2021-06-22T20:10:23","slug":"hawkins-inc-expands-pharmaceutical-ingredient-capabilities","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\/","title":{"rendered":"Hawkins, Inc. Expands Pharmaceutical Ingredient Capabilities"},"content":{"rendered":"<div class=\"mw_release\">\n<p>\n        <strong>Roseville, MN, June  22, 2021  (GLOBE NEWSWIRE) &#8212; <\/strong>Hawkins, Inc. (Nasdaq: HWKN), a leading specialty chemical company, today announced that it has completed a capital investment in its Minneapolis, MN facility to drive further growth in its pharmaceutical ingredient business. The total overall investment of approximately $5 million included automation capabilities and additional storage for raw materials and finished goods. The addition more than doubles the facility\u2019s pharmaceutical capacity in a controlled environment to support the industry\u2019s estimated demands and allows for larger quantity production campaigns.<\/p>\n<p>Patrick Hawkins, President and CEO, stated, \u201cThis expansion is consistent with our long-term growth strategy to make targeted investments in higher margin, faster growing markets. We believe these investments will help grow revenue in our pharmaceutical end markets in future years. In addition to the capital investment projects, over the last three years we have added to our pharmaceutical ingredient sales force to support this growing end market. We believe we will generate strong returns on these investments, especially given recent on-shoring trends, increased demands for these products, and overall growth in this industry.\u201d<\/p>\n<p>\n        <strong>About Hawkins, Inc.<\/strong><br \/>\n        <br \/>Hawkins, Inc. was founded in 1938 and is a leading specialty chemical company that distributes, blends and manufactures chemicals and other specialty ingredients for its Industrial, Water Treatment, and Health &amp; Nutrition customers. Headquartered in Roseville, Minnesota, and with 46 facilities in 22 states, the Company creates value for its customers through superb customer service and support, quality products and personalized applications. Hawkins, Inc. generated $597 million of revenue in fiscal 2021 and has approximately 750 employees. For more information, including registering to receive email alerts, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oQMHK6nEglHXU-oXvxgkEbwkPETGCP45n_Wsmcw5-roa2v0KFh_g882xh0O1qMTupj6po5VexwIVKZxDvWYJdyKcC5GMguaDUgd0oz4I7SfrJWmMoe4ba-Qol4Z9C-u_\" rel=\"nofollow noopener\" target=\"_blank\">www.hawkinsinc.com\/investors<\/a>.<\/p>\n<p align=\"center\">###<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1ODcwNyM0MjU0NjMyIzUwMDA2NjczOA==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/efda8fa6-0729-4b8a-a4ed-31b30f84a7fc\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Jeffrey P. Oldenkamp\r\nExecutive Vice President and Chief Financial Officer\r\n612\/331-6910\r\nir@hawkinsinc.com<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Roseville, MN, June 22, 2021 (GLOBE NEWSWIRE) &#8212; Hawkins, Inc. (Nasdaq: HWKN), a leading specialty chemical company, today announced that it has completed a capital investment in its Minneapolis, MN facility to drive further growth in its pharmaceutical ingredient business. The total overall investment of approximately $5 million included automation capabilities and additional storage for raw materials and finished goods. The addition more than doubles the facility\u2019s pharmaceutical capacity in a controlled environment to support the industry\u2019s estimated demands and allows for larger quantity production campaigns. Patrick Hawkins, President and CEO, stated, \u201cThis expansion is consistent with our long-term growth strategy to make targeted investments in higher margin, faster growing markets. We believe these investments will help grow revenue in &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Hawkins, Inc. Expands Pharmaceutical Ingredient Capabilities&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-505637","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Hawkins, Inc. Expands Pharmaceutical Ingredient Capabilities - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hawkins, Inc. Expands Pharmaceutical Ingredient Capabilities - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Roseville, MN, June 22, 2021 (GLOBE NEWSWIRE) &#8212; Hawkins, Inc. (Nasdaq: HWKN), a leading specialty chemical company, today announced that it has completed a capital investment in its Minneapolis, MN facility to drive further growth in its pharmaceutical ingredient business. The total overall investment of approximately $5 million included automation capabilities and additional storage for raw materials and finished goods. The addition more than doubles the facility\u2019s pharmaceutical capacity in a controlled environment to support the industry\u2019s estimated demands and allows for larger quantity production campaigns. Patrick Hawkins, President and CEO, stated, \u201cThis expansion is consistent with our long-term growth strategy to make targeted investments in higher margin, faster growing markets. We believe these investments will help grow revenue in &hellip; Continue reading &quot;Hawkins, Inc. Expands Pharmaceutical Ingredient Capabilities&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-22T20:10:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1ODcwNyM0MjU0NjMyIzUwMDA2NjczOA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Hawkins, Inc. Expands Pharmaceutical Ingredient Capabilities\",\"datePublished\":\"2021-06-22T20:10:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\\\/\"},\"wordCount\":274,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI1ODcwNyM0MjU0NjMyIzUwMDA2NjczOA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\\\/\",\"name\":\"Hawkins, Inc. Expands Pharmaceutical Ingredient Capabilities - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI1ODcwNyM0MjU0NjMyIzUwMDA2NjczOA==\",\"datePublished\":\"2021-06-22T20:10:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI1ODcwNyM0MjU0NjMyIzUwMDA2NjczOA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI1ODcwNyM0MjU0NjMyIzUwMDA2NjczOA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hawkins, Inc. Expands Pharmaceutical Ingredient Capabilities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hawkins, Inc. Expands Pharmaceutical Ingredient Capabilities - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\/","og_locale":"en_US","og_type":"article","og_title":"Hawkins, Inc. Expands Pharmaceutical Ingredient Capabilities - Market Newsdesk","og_description":"Roseville, MN, June 22, 2021 (GLOBE NEWSWIRE) &#8212; Hawkins, Inc. (Nasdaq: HWKN), a leading specialty chemical company, today announced that it has completed a capital investment in its Minneapolis, MN facility to drive further growth in its pharmaceutical ingredient business. The total overall investment of approximately $5 million included automation capabilities and additional storage for raw materials and finished goods. The addition more than doubles the facility\u2019s pharmaceutical capacity in a controlled environment to support the industry\u2019s estimated demands and allows for larger quantity production campaigns. Patrick Hawkins, President and CEO, stated, \u201cThis expansion is consistent with our long-term growth strategy to make targeted investments in higher margin, faster growing markets. We believe these investments will help grow revenue in &hellip; Continue reading \"Hawkins, Inc. Expands Pharmaceutical Ingredient Capabilities\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\/","og_site_name":"Market Newsdesk","article_published_time":"2021-06-22T20:10:23+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1ODcwNyM0MjU0NjMyIzUwMDA2NjczOA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Hawkins, Inc. Expands Pharmaceutical Ingredient Capabilities","datePublished":"2021-06-22T20:10:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\/"},"wordCount":274,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1ODcwNyM0MjU0NjMyIzUwMDA2NjczOA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\/","name":"Hawkins, Inc. Expands Pharmaceutical Ingredient Capabilities - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1ODcwNyM0MjU0NjMyIzUwMDA2NjczOA==","datePublished":"2021-06-22T20:10:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1ODcwNyM0MjU0NjMyIzUwMDA2NjczOA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1ODcwNyM0MjU0NjMyIzUwMDA2NjczOA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hawkins-inc-expands-pharmaceutical-ingredient-capabilities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Hawkins, Inc. Expands Pharmaceutical Ingredient Capabilities"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/505637","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=505637"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/505637\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=505637"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=505637"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=505637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}